IL251875D0 - Use of circulating cell-free rna for diagnosis and/or monitoring cancer - Google Patents

Use of circulating cell-free rna for diagnosis and/or monitoring cancer

Info

Publication number
IL251875D0
IL251875D0 IL251875A IL25187517A IL251875D0 IL 251875 D0 IL251875 D0 IL 251875D0 IL 251875 A IL251875 A IL 251875A IL 25187517 A IL25187517 A IL 25187517A IL 251875 D0 IL251875 D0 IL 251875D0
Authority
IL
Israel
Prior art keywords
diagnosis
circulating cell
free rna
monitoring cancer
cancer
Prior art date
Application number
IL251875A
Other languages
Hebrew (he)
Original Assignee
Liquid Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462080022P priority Critical
Priority to US201562214756P priority
Priority to US201562233935P priority
Priority to PCT/US2015/060602 priority patent/WO2016077709A1/en
Application filed by Liquid Genomics Inc filed Critical Liquid Genomics Inc
Publication of IL251875D0 publication Critical patent/IL251875D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
IL251875A 2014-11-14 2017-04-24 Use of circulating cell-free rna for diagnosis and/or monitoring cancer IL251875D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US201462080022P true 2014-11-14 2014-11-14
US201562214756P true 2015-09-04 2015-09-04
US201562233935P true 2015-09-28 2015-09-28
PCT/US2015/060602 WO2016077709A1 (en) 2014-11-14 2015-11-13 Use of circulating cell-free rna for diagnosis and/or monitoring cancer

Publications (1)

Publication Number Publication Date
IL251875D0 true IL251875D0 (en) 2017-06-29

Family

ID=55955114

Family Applications (1)

Application Number Title Priority Date Filing Date
IL251875A IL251875D0 (en) 2014-11-14 2017-04-24 Use of circulating cell-free rna for diagnosis and/or monitoring cancer

Country Status (9)

Country Link
US (1) US20180258489A1 (en)
EP (1) EP3218523B1 (en)
JP (1) JP2017538404A (en)
KR (1) KR20170083563A (en)
CN (1) CN107002132A (en)
AU (1) AU2015346185A1 (en)
CA (1) CA2965528A1 (en)
IL (1) IL251875D0 (en)
WO (1) WO2016077709A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
JP2020511137A (en) * 2017-03-17 2020-04-16 ナントミクス,エルエルシー Liquid biopsy for cfRNA
CN107012212B (en) * 2017-03-24 2018-03-02 刘长胜 Early diagnosis of cancer kit and its application based on Cell-free DNA
KR20190139314A (en) * 2017-05-03 2019-12-17 난토믹스, 엘엘씨 Tumor vs. Matched Normal cfRNA (TUMOR VS.MATCHED NORMAL cfRNA)
CN110621790A (en) * 2017-05-10 2019-12-27 南托米克斯有限责任公司 Circulating RNA for detecting, predicting and monitoring cancer
AU2018289369A1 (en) * 2017-06-20 2020-01-16 Nantomics, Llc Use of cell-free circulating rna (cfRNA) expression of PD-L1 and ERCC1 in plasma to monitor response to therapy in NSCLC
WO2019035075A1 (en) * 2017-08-17 2019-02-21 NantOmics, LLC. Dynamic changes in circulating free rna of neural tumors
WO2019094363A2 (en) * 2017-11-07 2019-05-16 Nanthealth Labs, Inc. Targeted cell free nucleic acid analysis
WO2019133391A1 (en) * 2017-12-20 2019-07-04 Nantomics, Llc Using cfrna for diagnosing minimal residual disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329179B1 (en) * 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US20090233276A1 (en) * 1998-09-22 2009-09-17 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
US20130029339A1 (en) * 2009-09-09 2013-01-31 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011154940A1 (en) * 2010-06-07 2011-12-15 Osnat Ashur-Fabian Methods and kits for diagnosing conditions related to hypoxia
US20130122499A1 (en) * 2011-11-14 2013-05-16 Viomics, Inc. System and method of detecting local copy number variation in dna samples
PT2809810T (en) * 2012-01-06 2020-02-14 Viomics Inc System and method of detecting rnas altered by cancer in peripheral blood
WO2014151006A2 (en) * 2013-03-15 2014-09-25 Genentech, Inc. Biomarkers and methods of treating pd-1 and pd-l1 related conditions

Also Published As

Publication number Publication date
KR20170083563A (en) 2017-07-18
AU2015346185A1 (en) 2017-05-04
EP3218523B1 (en) 2020-02-12
JP2017538404A (en) 2017-12-28
EP3218523A4 (en) 2018-04-04
CA2965528A1 (en) 2016-05-19
WO2016077709A1 (en) 2016-05-19
CN107002132A (en) 2017-08-01
US20180258489A1 (en) 2018-09-13
EP3218523A1 (en) 2017-09-20

Similar Documents

Publication Publication Date Title
IL251868D0 (en) Anti-tim3 antibodies and methods of use
PL3157512T3 (en) Use of cannabidiol in the treatment of epilepsy
IL247713D0 (en) 5-substituted indazole-3-carboxamides and preparation and use thereof
BR112017002408A2 (en) methods and systems to indicate the status of door operations
RU2017121326A (en) General easy chains and ways of their application
EP3171765A4 (en) Collection and analysis of data for diagnostic purposes
RU2016134947A (en) Derivatives of diaminopyrimidine benzenesulphone and their application
EP3191628A4 (en) Identification and use of circulating nucleic acids
ZA201703075B (en) Substituted chromanes and method of use
GB2535388B (en) System of living
HRP20181359T1 (en) Anti-jagged1 antibodies and methods of use
EP3179907A4 (en) Ecg patch and methods of use
DK3317284T3 (en) Benzoxazepine-oxazolidinone compounds and methods of use
RU2017121096A (en) Combined therapy, including application of the ox40-binding agonists and analogualists of the axis pd-1
EP3182901A4 (en) System and method for non-invasive analysis of bodily fluids
RU2017119428A (en) Combined therapy, including the use of ox40-connecting agonists and tigit inhibitors
RU2017102898A (en) Size and location of the application window on the basis of regions
HK1253093A1 (en) Methods of diagnosing and treating cancer
IL259783D0 (en) Methods of treatment of malignancies
DK3166937T3 (en) Anti-proliferative relations and procedures for use thereof
HK1232111A1 (en) Tissue ablation and monitoring thereof
ZA201605639B (en) Hppd variants and methods of use
DK3102673T3 (en) Methods and compositions for the treatment of beta-talassemi
HK1232140A1 (en) Micro-organoids, and methods of making and using the same
EP3201434A4 (en) Downhole tomographic imaging